fbpx

A Cancer Treatment Causes Side Effect of Night Vision

Research published in the Journal of Physical Chemistry Letters explained why photodynamic cancer therapy causes night vision in patients. Photodynamic therapy is a form of cancer treatment that uses light to destroy malignant cells. The interesting side effect patients have reported is night vision seen as silhouettes and outlines in the dark. Only now have researchers discovered the mechanics of this phenomenon.

The Mechanics of Night Vision

Photodynamic therapy involves injections of chlorin e6, a photosensitive compound. It’s the reaction between chlorin e6 and rhodopsin in the retinal photoreceptors rods that causes the apparent night vision to occur. Normally we see with visible light because of a compound in our eye called retinal being triggered by visible light. After triggering, retinal separates from rhodopsin, a light-sensitive protein in the retinas of our eyes, and an electrical signal is transmitted to our brain to interpret what we see. In the case of night vision seen by these cancer patients, infrared light combined with the chlorin e6 changes retinal in the same way it does under visible light conditions. “This explains the increase in night-time visual acuity,” chemist Antonio Monari, from the University of Lorraine in France tells CNRS (French National Centre for Scientific Research).

Using Molecular Simulation to Understand Chemical Reactions

The researchers used molecular simulation to model the movements of individual atoms as well as the breaking or creating of chemical bonds. It took several months of testing various simulations with millions of calculations before it was able to accurately model the chemical reaction caused by infrared radiation. “For our simulation we placed a virtual rhodopsin protein inserted in its lipid membrane in contact with several chlorin e6 molecules and water, or several tens of thousands of atoms,” Monari told CNRS.

Molecular simulation is a powerful tool and can help us better understand fundamental mechanisms. For example, it can help understand why certain DNA lesions are better repaired than others and help select the best therapeutic molecules by mimicking their interaction in a simulated model.

Reference: https://www.sciencealert.com/scientists-have-figured-out-how-a-cancer-treatment-gives-patients-night-vision

Featured Posts

SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read More
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read More
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read More
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read More
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more